T0	Participants 245 400	patients with severe aplastic anemia (SAA) treated with anti-lymphocyte globulin (ALG), cyclosporin (CyA) and granulocyte colony-stimulating factor (G-CSF)
T1	Participants 724 850	multicenter prospective trial in 77 SAA patients treated with horse ALG (15 mg/kg/day day1-5) and CyA (5 mg/kg/day day 1-180).
T2	Participants 851 875	Patients were randomized
T3	Participants 1463 1512	Thirteen patients (5 in group A and 8 in group B)
T4	Participants 2085 2125	patients with SAA receiving ALG and CyA.